| Description | Traxoprodil Mesylate is a potent noncompetitive N-methyl-D-aspartate (NMDA) receptors antagonist and has selective for the NR2B subunit. |
| molecular weight | 423.52 |
| Molecular formula | C21H29NO6S |
| CAS | 188591-67-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. DePoy LM, Zimmermann KS, Marvar PJ, Gourley SL. Induction and Blockade of Adolescent Cocaine-Induced Habits. Biol Psychiatry. 2017 Apr 1;81(7):595-605. doi: 10.1016/j.biopsych.2016.09.023. Epub 2016 Oct 6. PubMed PMID: 27871669; PubMed Central PMCID: PMC5359769. 2. Stasiuk W, Serefko A, Szopa A, Wyska E, Świąder K, Wlaź P, Poleszak E. Traxoprodil augments the antidepressant-like activity of agomelatine but not of mianserin or tianeptine in the forced swim test in mice. Pharmacol Rep. 2016 Oct;68(5):960-3. doi: 10.1016/j.pharep.2016.04.013. Epub 2016 May 4. PubMed PMID: 27371898. 3. Higgins GA, Silenieks LB, MacMillan C, Sevo J, Zeeb FD, Thevarkunnel S. Enhanced attention and impulsive action following NMDA receptor GluN2B-selective antagonist pretreatment. Behav Brain Res. 2016 Sep 15;311:1-14. doi: 10.1016/j.bbr.2016.05.025. Epub 2016 May 11. PubMed PMID: 27180168. 4. Nagy D, Stoiljkovic M, Menniti FS, Hajós M. Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy. Neuropsychopharmacology. 2016 May;41(6):1486-94. doi: 10.1038/npp.2015.298. Epub 2015 Sep 25. PubMed PMID: 26404843; PubMed Central PMCID: PMC4832008. |